These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2274522)

  • 1. Electrical stimulation studies with quinacainol, a putative 1C agent, in the anaesthetised rat.
    Howard PG; Walker MJ
    Proc West Pharmacol Soc; 1990; 33():123-7. PubMed ID: 2274522
    [No Abstract]   [Full Text] [Related]  

  • 2. Quinacainol, a new antiarrhythmic with class I antiarrhythmic actions in the rat.
    Howard PG; MacLeod BA; Walker MJ
    Eur J Pharmacol; 1992 Aug; 219(1):1-8. PubMed ID: 1397036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Block of NA+ and K+ currents in rat ventricular myocytes by quinacainol and quinidine.
    Pugsley MK; Walker MJ; Saint DA
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):60-5. PubMed ID: 15730436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic actions of a long acting verapamil analogue, anipamil, in pigs.
    Ries C; Harvie CJ; Walker MJ; Pugsley MK
    Proc West Pharmacol Soc; 1993; 36():95-8. PubMed ID: 8378404
    [No Abstract]   [Full Text] [Related]  

  • 5. [1st experiences with the clinical use of a new antiarrhythmic agent: bunaftide].
    Lotto A; Lomanto B; Bossi M
    Cardiol Prat; 1972; 23(2):123-33. PubMed ID: 5073277
    [No Abstract]   [Full Text] [Related]  

  • 6. Electrically induced arrhythmias in the rat.
    Walker MJ; Beatch GN
    Proc West Pharmacol Soc; 1988; 31():167-70. PubMed ID: 3211899
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 8. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
    Diederich KW; Boyksen D
    Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective effects of I(1)-antihypertensive agent moxonidine against neurogenic cardiac arrhythmias in halothane-anesthetized rabbits.
    Poisson D; Christen MO; Sannajust F
    J Pharmacol Exp Ther; 2000 Jun; 293(3):929-38. PubMed ID: 10869394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elimination of disorders in the electrical stability of the heart during postinfarct cardiosclerosis by using a factor that induces GABA accumulation in the brain].
    Abdikaliev NA; Shabunina EV; Meerson FZ
    Biull Eksp Biol Med; 1989 Feb; 107(2):152-4. PubMed ID: 2493823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Actions of sparteine and sparteine derivatives on the heart and circulation].
    Raschack M
    Arzneimittelforschung; 1974 May; 24(5):753-9. PubMed ID: 4408029
    [No Abstract]   [Full Text] [Related]  

  • 12. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE; Kaplan HR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic properties of tetrodotoxin against occlusion-induced arrhythmias in the rat: a novel approach to the study of the antiarrhythmic effects of ventricular sodium channel blockade.
    Abraham S; Beatch GN; MacLeod BA; Walker MJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1166-73. PubMed ID: 2557414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative characteristic of sodium blocking properties of anti-arrhythmia agents on isolated rats cardiomyocytes].
    Khankoeva AI; Dukhanin AS; Galenko-Iaroshevskií PA
    Biull Eksp Biol Med; 1997 Jun; 123(6):666-8. PubMed ID: 9280522
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative evaluation of the antiarrhythmic effect of derivatives of diphenylacetic acid and novocaine amide].
    Serdiuk EN; Koval'chuk LA
    Farmakol Toksikol; 1971; 34(2):168-70. PubMed ID: 5563386
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacologic differentiation between various anti-arrhythmics in animal experiments].
    Lillie C; Kobinger W
    Adv Clin Pharmacol; 1978; 16():3-16. PubMed ID: 28644
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of antiarrhythmia agents and sympathetic regulation of the heart].
    Kaverina NV; Darinskiĭ NV; Berdiaev SIu
    Vestn Akad Med Nauk SSSR; 1982; (5):23-8. PubMed ID: 7102090
    [No Abstract]   [Full Text] [Related]  

  • 18. Do related kappa agonists produce similar effects on cardiac ion channels?
    Pugsley MK; Hayes ES; Saint DA; Walker MJ
    Proc West Pharmacol Soc; 1995; 38():25-7. PubMed ID: 7480011
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular and antiarrhythmic properties of protamine in rats.
    Pugsley MK; Kalra V; Froebel-Wilson S; Aardalen K
    Proc West Pharmacol Soc; 2001; 44():33-6. PubMed ID: 11793988
    [No Abstract]   [Full Text] [Related]  

  • 20. Derivatives of 2-mercaptyobenzenesulphonamide. XIII. Syntheses and somepharmacological properties of 1-4-chloro-2-(dialkylaminoalkylthio)-5- methylbenzenesulphonyl)-2-imidazolidinone hydrochlorides.
    Brzozowski Z; Pomarnacka E; Kosmala M; Filczewski M; Oledzka K; Lewandowski K; Miłobedzka J
    Acta Pol Pharm; 1993; 50(4-5):359-64. PubMed ID: 8036922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.